GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Initiator Pharma AS (OSTO:INIT) » Definitions » Short Percentage of Float

Initiator Pharma AS (OSTO:INIT) Short Percentage of Float


View and export this data going back to 2017. Start your Free Trial

What is Initiator Pharma AS Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Initiator Pharma AS's Short Percentage of Float

For the Biotechnology subindustry, Initiator Pharma AS's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Initiator Pharma AS's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Initiator Pharma AS's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Initiator Pharma AS's Short Percentage of Float falls into.


;
;

Initiator Pharma AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Initiator Pharma AS (OSTO:INIT) » Definitions » Short Percentage of Float
Comparable Companies
OSTO:IRLAB A OSTO:CANTA OSTO:ONCO OSTO:IVACC XSAT:CESSA OSTO:LIPUM OSTO:ISOFOL OSTO:ACE OSTO:XBRANE OSTO:XINT VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Co/ COBIS, Ole Maaloesvej 3, Copenhagen, DNK, 2200
Website
https://www.initiatorpharma.com
Initiator Pharma AS is a research and development company engaged in the pharmaceutical development of drugs to be used for erectile dysfunction, depression, and pain. It Research is focused in the area of monoamine reuptake inhibitors.

Initiator Pharma AS Headlines

No Headlines